Journal of Alzheimer's Disease

15/11/2025

Biomarcadores para o diagnóstico diferencial entre as síndromes demenciais

14/11/2025

The future of brain science in Texas just got a major boost. The University of Texas System and UT San Antonio have officially unveiled the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility in the South Texas Medical Center that brings patient care, therapy,...

14/11/2025

The 103,000-square-foot facility is the new home of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.

14/11/2025

New effort is modeled after the state’s long-running cancer research institute

13/11/2025

Hearing loss is linked to lower brain volume and a higher risk for dementia, especially in those with APOEε4, new research shows.

13/11/2025

Woman Born Without Most of Her Brain Celebrates Her 20th Birthday
— Alex Simpson wasn't expected to survive past age 4
by Judy George, Deputy Managing Editor, MedPage Today
November 12, 2025 • 2 min read

13/11/2025

Young-Onset Dementia Linked to Sharply Increased Death Risk
— Survival rates varied considerably by clinical type of disease
by Judy George, Deputy Managing Editor, MedPage Today
November 4, 2025 • 3 min read

13/11/2025

New research reveals a promising new target to slow the progression of this devastating disease.

10/11/2025

A new clinical trial, published in the Journal of Alzheimer's Disease, offers promising insights for the field of novel pharmacological therapies for Alzheimer's disease (AD). The investigation, led by Dr. Francisney Nascimento, Professor of Clinical Pharmacology at the School of Medicine of the Federal University of Latin American Integration (UNILA), Foz do Iguaçu, Brazil, focused on the effects of very low doses of a balanced cannabinoid extract – containing tetrahydrocannabinol (THC) and cannabidiol (CBD) – in patients with AD dementia. The trial results suggest that a balanced THC-CBD extract may improve cognitive function in patients with Alzheimer's-associated dementia, with a favorable safety profile. Read more here: https://journals.sagepub.com/page/alz/news/low-dose-cannabinoids-alleviate-cognitive-symptoms

Subscription and open access journals from Sage, the world's leading independent academic publisher.

10/11/2025

A new peer-reviewed article published in the Journal of Alzheimer's Disease, by the Alzheimer's Research and Prevention Foundation, reveals compelling evidence that air pollution and climate stress are major (modifiable) risk factors for Alzheimer's disease, and introduces a revolutionary prevention plan grounded in evidence based medicine. Read more:

A new peer-reviewed article published in the Journal of Alzheimer's Disease, by the Alzheimer's Research and Prevention Foundation, reveals compelling evidence that air pollution and climate stress are major (modifiable) risk factors for Alzheimer's disease, and introduces a revolutionary prevention...

09/11/2025

For decades, scientists have hunted for the biological spark that ignites Alzheimer's disease. A sweeping new review now points skyward: the air we

08/11/2025

Amyloid antibody therapy

In partnership with The Royal Society of Medicine, this meeting has been developed, organised, and funded by Eli Lilly and Company. It is intended for healthcare professionals in the United Kingdom only.